Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Holen

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Cancer Drug Targets|December 23, 2009
Anti-tumour effects of bisphosphonates--what have we learned from in vivo models?H K Brown, I Holen
International Journal of Breast Cancer|February 15, 2012
Multidrug resistance in breast cancer: from in vitro models to clinical studiesN S Wind, I Holen
Cancer Treatment Reviews|March 9, 2012
Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonatesC Wilson, I Holen, R E Coleman
Experimental Cell Research|June 1, 1995
Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acidH Blankson, I Holen, P O Seglen
Cell Biology and Toxicology|January 1, 1990
Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphateS O Mikalsen, I Holen, T Sanner
Journal of Toxicology and Environmental Health|January 1, 1990
Effects of dinitrotoluenes on morphological cell transformation and intercellular communication in Syrian hamster embryo cellsI Holen, S O Mikalsen, T Sanner
Biomedica Biochimica Acta|January 1, 1991
Role of cyclic nucleotides in the control of hepatic autophagyI Holen, P B Gordon, P O Seglen
The Biochemical Journal|June 15, 1992
Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrityI Holen, P B Gordon, P O Seglen
Biomedica Biochimica Acta|January 1, 1991
Effects of adrenergic agonists and antagonists on autophagic activity in isolated rat liver cellsP B Gordon, I Holen, P O Seglen
Current Pharmaceutical Design|August 21, 2010
Combined therapies of bone disease with bisphosphonatesS P Syddall, P D Ottewell, I Holen
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Cancer Drug Targets|December 23, 2009
Anti-tumour effects of bisphosphonates--what have we learned from in vivo models?H K Brown, I Holen
International Journal of Breast Cancer|February 15, 2012
Multidrug resistance in breast cancer: from in vitro models to clinical studiesN S Wind, I Holen
Cancer Treatment Reviews|March 9, 2012
Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonatesC Wilson, I Holen, R E Coleman
Experimental Cell Research|June 1, 1995
Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acidH Blankson, I Holen, P O Seglen
Cell Biology and Toxicology|January 1, 1990
Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphateS O Mikalsen, I Holen, T Sanner
Journal of Toxicology and Environmental Health|January 1, 1990
Effects of dinitrotoluenes on morphological cell transformation and intercellular communication in Syrian hamster embryo cellsI Holen, S O Mikalsen, T Sanner
Biomedica Biochimica Acta|January 1, 1991
Role of cyclic nucleotides in the control of hepatic autophagyI Holen, P B Gordon, P O Seglen
The Biochemical Journal|June 15, 1992
Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrityI Holen, P B Gordon, P O Seglen
Biomedica Biochimica Acta|January 1, 1991
Effects of adrenergic agonists and antagonists on autophagic activity in isolated rat liver cellsP B Gordon, I Holen, P O Seglen
Current Pharmaceutical Design|August 21, 2010
Combined therapies of bone disease with bisphosphonatesS P Syddall, P D Ottewell, I Holen
Pageof 5